Medicare coverage of Novo Nordisk's Wegovy could cost up to $145B annually08/29/2024 Medicare coverage of Novo Nordisk’s Wegovy could cost up to $145B annually Source: Seekingalpha
Medicare coverage of Novo Nordisk’s Wegovy could cost up to $145B annually08/28/2024 aprott/iStock by way of Getty Images Novo Nordisk’s (NVO) weight reduction drug Wegovy (semaglutide), which could be prescribed to Medicare beneficiaries who’re each overweight and have…
